Search Results
You are looking at 1 - 1 of 1 items for
- Author: Hubertus Jarry x
- Refine by access: All content x
Department of Clinical and Experimental Endocrinology, University of Göttingen, 37075 Göttingen, Germany
Search for other papers by Martina Böttner in
Google Scholar
PubMed
Department of Clinical and Experimental Endocrinology, University of Göttingen, 37075 Göttingen, Germany
Search for other papers by Julie Christoffel in
Google Scholar
PubMed
Department of Clinical and Experimental Endocrinology, University of Göttingen, 37075 Göttingen, Germany
Search for other papers by Hubertus Jarry in
Google Scholar
PubMed
Department of Clinical and Experimental Endocrinology, University of Göttingen, 37075 Göttingen, Germany
Search for other papers by Wolfgang Wuttke in
Google Scholar
PubMed
Hormone replacement therapy (HRT) has been used for several decades to treat menopausal discomforts. However, in the light of recent studies that draw attention to the potential hazards of conventional HRT, various attempts have been undertaken to search for alternatives to classical HRT. Phytoestrogens are claimed to be capable of positively influencing menopausal symptoms, including hot flushes. We designed a long-term study of 3 months to assess the effects of subcutaneous and orally fed 17β-estradiol (E2), as well as the actions of resveratrol (RES) on pituitary function in female rats. Our results have demonstrated that RES binds with a 10-fold lower affinity to estrogen receptor (ER)-α than to ERβ. The data from the in vivo study revealed that a dosage of 5 μg and 50 μg RES/kg bodyweight per day given to ovariectomized (OVX) rats achieved serum levels of 1.0 and 8.1 μM respectively. Long-term treatment of OVX rats with RES revealed no estrogenic potential on pituitary function in vivo as assessed by LH and prolactin secretion and by regulation of mRNAs for LHα, LHβ, and GnRH receptor. Subcutaneous treatment with E2 in silastic capsules exerted stronger effects on LH and prolactin secretion, as well as on LHβ, LHα, GnRH receptor, and ERβ mRNA regulation compared with orally applied estradiol benzoate despite comparable serum levels. Levels of aryl hydrocarbon receptor (AhR) mRNA in the pituitary were increased following OVX and attenuated by long-term E2 treatment, whereas RES did not modulate AhR mRNA expression.